Literature DB >> 27112311

Pharmacokinetics of Phenobarbital in Microenema Via Macy Catheter Versus Suppository.

Y W Francis Lam1, Ansom Lam2, Brad Macy3.   

Abstract

CONTEXT: The oral route is compromised for nearly all patients approaching death. When agitation, seizures, or other intractable symptoms occur, a quick, discreet, comfortable, and effective alternate route for medication delivery that is easy to administer in the home setting is highly desirable.
OBJECTIVES: To characterize the early absorption profile, variability, and comfort of phenobarbital given in microenema suspensions delivered via the Macy Catheter(®) (MC) vs. the same dose given via suppository.
METHODS: This was a randomized, open-label, crossover study comparing the early absorption profile of equal doses of phenobarbital administered rectally in three treatment phases: phenobarbital suppository and two different microenemas with phenobarbital tablets crushed and suspended in 6 mL (MC-6) or 20 mL (MC-20) of tap water.
RESULTS: Mean plasma phenobarbital concentrations at 10 minutes were 12× higher for MC-20 and 8× higher for MC-6 compared to suppository. Concentrations achieved in 30 minutes via MC-20 took almost three hours to achieve with suppository. Mean AUC values were higher for MC-20 and MC-6 (82% and 46%, respectively) vs. suppository (P < 0.05). There was less variability in absorption for MC-20 and MC-6 (1.4- to 1.9-fold difference) compared to a 4.4-fold difference via suppository. MC administrations were reported as "not uncomfortable" compared to suppositories, which were reported as "mildly uncomfortable" (P < 0.05).
CONCLUSION: These results suggest phenobarbital oral tablets crushed and suspended in water and administered via the MC is superior to suppository in delivering the medication reliably and rapidly.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Rectal administration; hospice care; phenobarbital; suppository

Mesh:

Substances:

Year:  2016        PMID: 27112311     DOI: 10.1016/j.jpainsymman.2015.12.339

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  5 in total

Review 1.  Hospice in heart failure: why, when, and what then?

Authors:  Jeffrey L Spiess
Journal:  Heart Fail Rev       Date:  2017-09       Impact factor: 4.214

2.  A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings.

Authors:  Akilesh Honasoge; Neal Lyons; Kathleen Hesse; Braden Parker; Robert Mokszycki; Kelly Wesselhoff; Rolla Sweis; Erik B Kulstad
Journal:  J Vis Exp       Date:  2016-11-09       Impact factor: 1.355

3.  Promoting Excellence in Symptom Management Case Series: Case Study: A New Intervention for Rapid End-of-Life Symptom Control in the Home Setting.

Authors:  Kathryn Paez; Meegan Gregg; Charlea T Massion; Brad Macy
Journal:  J Hosp Palliat Nurs       Date:  2017-10-31       Impact factor: 1.918

Review 4.  Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic.

Authors:  Jenny K W Lam; Chucky C K Cheung; Michael Y T Chow; Emily Harrop; Susie Lapwood; Stephen I G Barclay; Ian C K Wong
Journal:  Adv Drug Deliv Rev       Date:  2020-11-01       Impact factor: 15.470

5.  Evading Seizures: Phenobarbital Reintroduced as a Multifunctional Approach to End-of-Life Care.

Authors:  Helen Senderovich; Sarah Waicus; Keisa Mokenela
Journal:  Case Rep Oncol       Date:  2022-03-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.